Interaction of vitamin E isoforms on asthma and allergic airway disease

Abstract

Prospective epidemiological studies, observational cross-sectional studies and some randomised prevention trials have demonstrated inconsistent findings of the impact of vitamin E on asthma risk. The goals of this study were to explore whether this differing association of vitamin E on asthma risk is due to an interaction of vitamin E isoforms. To address this question, in a population-based asthma incidence study we assessed the interaction between the plasma concentrations of vitamin E isoforms α-tocopherol and γ-tocopherol on asthma risk. Second, to understand the mechanisms of any interaction of these isoforms, we conducted experimental supplementation of α-tocopherol and γ-tocopherol isoforms in mice on the outcome of allergic airway inflammation. We found that in the highest γ-tocopherol tertile, low levels of α-tocopherol were associated with increased asthma risk, while highest tertile α-tocopherol levels trended to be protective. Similarly, in a mouse model of asthma, diet supplementation with α-tocopherol decreased lung inflammation in response to house dust mite (HDM) challenge. In contrast, diet supplementation with γ-tocopherol increased lung inflammation in response to HDM. These human and animal studies provide evidence for the competing effects of the vitamin E isoforms, in physiological concentrations, on asthma and allergic airway disease.

Keywords: Allergic lung disease; Asthma; Asthma Epidemiology; Asthma Mechanisms.

Figure 1

Interaction of plasma levels of α-tocopherol and γ-tocopherol on asthma risk.

Figure 2

Opposing effects of diet supplementation with d-α-tocopherol (αT) and d-γ-tocopherol (γT) on leucocyte infiltration into the mouse lung, and impact on bronchoalveolar lavage (BAL) cytokines. HDM, house dust mite; IL, interleukin.